Linda M Richardson
CIK 1595064 · Chief Commercial Officer · last filed 2025-09-17
Linda M Richardson is a Chief Commercial Officer who has filed 27 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for ALT, was dated Sep 17, 2025. Across all open-market trades the lifetime net is −$88.7K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
27
-$88.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALT | Chief Commercial Officer | — | $2.61 | — | $0 | 1 | 2025-09-17 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | EVP & Chief Commercial Officer | 43,291 | $19.00 | $822.5K | $0 | 15 | 2023-02-16 |
| CHIMERIX INC (CMRX) Delisted | Chief Commercial Officer | 54,161 | $8.54 | $462.5K | -$88.7K | 10 | 2018-05-15 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-17 | ALT | Grant (A) | — | $0 | EDGAR |
| 2023-11-13 | — | Mixed | −43,291 | -$822.5K | |
| 2023-02-16 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −386 | -$8.2K | EDGAR |
| 2023-01-31 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +12,200 | $0 | EDGAR |
| 2023-01-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −1,600 | -$19.8K | EDGAR |
| 2022-09-06 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −597 | -$10.8K | EDGAR |
| 2022-08-17 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −124 | -$2.3K | EDGAR |
| 2022-05-17 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −124 | -$2.2K | EDGAR |
| 2022-02-17 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −171 | -$2.7K | EDGAR |
| 2022-02-15 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −529 | -$7.9K | EDGAR |